Graftless TSFE Via Self-tapping Implants
Recruiting
N/A
Interventional Study
Edentulous Posterior Maxilla
Maxillary Sinus Pneumatization
Alveolar Bone Atrophy
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 80
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 20 (estimated)
- Sponsor
- Sana'a University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This prospective clinical trial aims to evaluate the efficiency, safety, and reliability of a minimally invasive graftless transcrestal sinus lifting approach with simultaneous dental implant placement in patients with edentulous posterior maxilla and limited residual bone height.
The study investigates bone formation beneath the Schneiderian membrane, implant stability, osseointegration, and lon…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Adults aged 18-80 years.
2. Patients with edentulous posterior maxilla.
3. Residual bone height approximately 4-6 mm.
4. Indicated for transcrestal sinus membrane elevation.
5. Good general health (ASA I or II).
6. Ability to provide written informed consent.
7. Willingness t…
Contacts
No contact information available.